TCG Crossover Management LLC 13D and 13G filings for Cogent Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-11-17 3:39 pm Purchase | 2021-11-05 | 13G | Cogent Biosciences, Inc. COGT | TCG Crossover Management LLC | 2,716,042 6.800% | 706,054 (+35.13%) | Filing |
| 2021-07-08 1:50 pm Purchase | 2021-06-28 | 13G | Cogent Biosciences, Inc. COGT | TCG Crossover Management LLC | 2,009,988 5.200% | 2,009,988 (New Position) | Filing |